检索

期
标题
作者
编号 2 (2023)
Cardiometabolic risk factors in women undergoing the menopausal transition and the potential of drospirenone-containing contraceptive in the correction of the identified abnormalities
Tolstov S., Salov I., Rebrov A.
PDF
(Rus)
编号 10 (2023)
Controversial issues of antenatal glucocorticoid use in fetal growth retardation
Leonova A., Kan N., Tyutyunnik V., Borisova A., Gasymova S.
PDF
(Rus)
编号 4 (2023)
Excess adipose tissue and chronic subclinical inflammation in patients with polycystic ovary syndrome
Kirillova E., Krechetova L., Vtorushina V., Ivanets T., Chernukha G.
PDF
(Rus)
编号 4 (2024)
The concept of epigenetic modifications in fetal metabolic programming
Tezikov Y., Lipatov I., Tyutyunnik V., Kan N., Kurbanova A.
PDF
(Rus)
编号 8 (2021)
Relationship between the severity of endothelial dysfunction and metabolic disorders and the severity of climacteric syndrome
Tolstov S., Salov I., Rebrov A.
PDF
(Rus)
编号 4 (2016)
Effect of a sibutramine/metformin combination on anti-Mffllerian hormone level, carbohydrate and lipid metabolisms in therapy for polycystic ovary syndrome in women with metabolic syndrome
Andreeva E., Grigoryan O., Volevodz N., Melnichenko G.
PDF
(Rus)
编号 6 (2016)
Obesity and female reproductive health
Aganezova N., Aganezov S.
PDF
(Rus)
编号 9 (2020)
“Nonclassical effects” of vitamin D in menopausal women
Andreeva E., Sheremetyeva E., Manushakyan G.
PDF
(Rus)
编号 5 (2012)
ROLE OF STATINS IN THE CORRECTION OF ENDOCRINE AND METABOLIC DISORDERS IN POLYCYSTIC OVARY SYNDROME
CHERNUKHA G., NEMOVA Y., BLINOVA I.
PDF
(Rus)
编号 1 (2022)
Role of insulin resistance in the mechanisms of adaptation and development of female reproductive system disease
Lipatov I., Tezikov Y., Tyutyunnik V., Kan N., Kuzmina A., Zumorina E., Amosov M.
PDF
(Rus)
编号 2 (2011)
ENDOCRINE AND METABOLIC CHARACTERISTICS OF PATIENTS WITH DIFFERENT PHENOTYPES OF POLYCYSTIC OVARY SYNDROME
CHERNUKHA G., BLINOVA I., KUPRASHVILI M.
PDF
(Rus)
编号 2 (2017)
Role of proand contrinsular factors in the development of obstetric pathology
Linde V., Palieva N., Botasheva T., Avrutskaya V., Dudareva M.
PDF
(Rus)
编号 2 (2011)
MENOPAUSAL METABOLIC SYNDROME AND HORMONE REPLACEMENT THERAPY
SALOV I., TOLSTOV S., MYCHKA V., KIRILLOVA M., VOICHENKO N., ZHERNAKOVA Y., KUZNETSOVA I.
PDF
(Rus)
编号 10 (2021)
Body mass index, body composition, and metabolic profile of patients with polycystic ovary syndrome
Chernukha G., Miroshina E., Kuznetsov S., Ivanov I.
PDF
(Rus)
编号 6 (2010)
PREVENTION OF METABOLIC SYNDROME AFTER MEDICAL ABORTION
SEROV V., ZAVALKO A., Serov V., Zavalko A.
编号 3 (2021)
Identity of preeclampsia and metabolic syndrome clinical manifestations: searching for substantiation
Lipatov I., Tezikov Y., Azamatov A., Shmakov R.
PDF
(Rus)
编号 6 (2009)
Prognostic criteria for the proliferative potential of the endometrium in the perimenopausal period
Grishchenko V., Kachailo I., Muryzina I.
编号 6 (2017)
FEATURES OF SOME VASOACTIVE HORMONES AND VASCULAR FACTORS IN WOMEN WITH METABOLIC SYNDROME AND THEIR INFLUENCE ON THE DEVELOPMENT OF OBSTETRIC COMPLICATIONS
Palieva N., Botasheva T., Linde V., Avrutskaya V., Zheleznyakova E.
PDF
(Rus)
编号 3 (2021)
Polycystic ovary syndrome and gut microbiota
Chernukha G., Miroshina E., Priputnevich T.
PDF
(Rus)
编号 6 (2015)
OPTIMIZATION OF MENOPAUSAL HORMONE THERAPY-RELATED RISKS: THERAPY WITH TRANSDERMAL ESTROGENS ALONE OR IN COMBINATION WITH MICRONIZED PROGESTERONE. ADVANTAGES AGAINST METABOLIC RISKS AND ARTERIAL THROMBOSIS
Yureneva S.
PDF
(Rus)
编号 2 (2020)
Weight gain in perimenopausal women: methods for assessing the body composition and maintenance tactics
Yureneva S., Komedina V., Kuznetsov S.
PDF
(Rus)
编号 7 (2012)
PROGNOSTIC VALUE OF PLACENTAL GROWTH FACTOR IN REDUCING THE FUNCTIONAL ACTIVITY OF A FORMING CHORION IN PREGNANT WOMEN WITH METABOLIC SYNDROME
SAVELYEVA I., KONEV V., BARINOV S., LETUCHIKH A., LUBAVINA A.
PDF
(Rus)
编号 9 (2020)
Pregnancy is a natural model of metabolic syndrome: results of a dynamic study of physiological gestation
Lipatov I., Tezikov Y., Shmakov R., Azamatov A., Martynova N.
PDF
(Rus)
编号 5 (2019)
Menopause, obesity, and comorbidity: possibilities of menopausal hormone therapy
Protasova A., Yureneva S., Bairamova N., Komedina V.
PDF
(Rus)
编号 2 (2022)
Role of insulin resistance in the mechanisms of adaptation and development of disease in postpartum and early neonatal periods
Lipatov I., Tezikov Y., Tyutyunnik V., Kan N., Kuzmina A., Zumorina E., Yakusheva A.
PDF
(Rus)
编号 11 (2018)
Predicting impairment of pre-lactation transformation and preventing lactogenesis failure in metabolic syndrome
Tezikov Y., Lipatov I., Pechkurov D., Tyutyunnik V., Kan N., Protasov A., Kovyazina I.
PDF
(Rus)
编号 2 (2011)
PREVALENCE OF OBESITY, ABNORMAL WEIGHT GAIN, AND METABOLIC SYNDROME IN PREGNANT WOMEN OF THE FAR NORTH
SUPLOTOVA L., SMETANINA S., NOVAKOVSKAYA N.
PDF
(Rus)
编号 10 (2017)
Obesity, metabolic syndrome, and thrombophilia
Khromylev A., Makatsaria A.
PDF
(Rus)
1 - 28 的 28 信息

检索提示:

  • 检索的名词区分大小写
  • 常用字词将被忽略
  • 默认情况下只有在查询结果满足所有检索词才返回（例如，隐含AND）
  • 使用OR结合多个检索词，便于查找含有这些检索词的文章，例如education OR research
  • 使用括号来创建更复杂的查询; 例如：archive ((journal OR conference) NOT theses)
  • 使用引号检索一个完整的词组; 例如： "open access publishing"
  • 使用-或者NOT排除一个检索词; 例如：online -politics or online NOT politics
  • 在检索词里使用 *作为通配符匹配任何字符序列; 例如., soci* morality 将符合含有 "sociological" or "societal"的词语
##common.cookie##